Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Richard Willke"'
Autor:
Devin Incerti, John Browne, Caroline Huber, Christine L. Baker, Geoff Makinson, Amir Goren, Richard Willke, Warren Stevens
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Although there has been growing attention to the measurement of unmet need, which is the overall epidemiological burden of disease, current measures ignore the burden that could be eliminated from technological advances or more ef
Externí odkaz:
https://doaj.org/article/6a8811dec20541adad9f9fcd06044c4a
Publikováno v:
International Journal of Technology Assessment in Health Care. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::016cea84ff220787f92e3a6094539e9c
https://doi.org/10.1017/s0266462322003324
https://doi.org/10.1017/s0266462322003324
Publikováno v:
Journal of managed carespecialty pharmacy. 28(3)
Over the past decade, we have witnessed unprecedented, groundbreaking innovation in pharmaceuticals. This has been particularly true in oncology, where new therapies have increased survival and at times offered clinical cure. However, the impact of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53a4cca283045c82944f2964c4521ab
https://pubmed.ncbi.nlm.nih.gov/35100007
https://pubmed.ncbi.nlm.nih.gov/35100007
Autor:
Elisabeth M. Oehrlein, Silke Schoch, Mehmet Burcu, Julia F. McBeth, Jennifer Bright, Chris L. Pashos, Richard Willke, T. Rosie Love, T. Joseph Mattingly, Eleanor M. Perfetto
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 26(1)
The Joint ISPOR-ISPE Special Task Force on Real-World Evidence included patient/stakeholder engagement as a recommended good procedural practice when designing, conducting, and disseminating real-world evidence (RWE). However, there are no guidelines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c737a96bcafe2764bedcd87f26ff12ed
https://pubmed.ncbi.nlm.nih.gov/35863944
https://pubmed.ncbi.nlm.nih.gov/35863944
Autor:
Caroline Huber, Amir Goren, Geoff Makinson, Christine L. Baker, Warren Stevens, John Browne, Richard Willke, Devin Incerti
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Health Services Research
BMC Health Services Research
Background Although there has been growing attention to the measurement of unmet need, which is the overall epidemiological burden of disease, current measures ignore the burden that could be eliminated from technological advances or more effective u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1073a83e96071b325030705be6ae8a
https://hdl.handle.net/10468/9226
https://hdl.handle.net/10468/9226
Publikováno v:
Journal of Clinical Oncology. 39:e18823-e18823
e18823 Background: Over the past decade, perhaps no single area of the health sector has seen as much groundbreaking innovation as pharmaceuticals. This has been especially true in oncology, where promising curative treatments have been initially cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b14dfb7f9761998f836ab4645a9a2448
https://doi.org/10.1200/jco.2021.39.15_suppl.e18823
https://doi.org/10.1200/jco.2021.39.15_suppl.e18823